Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Emcure Pharmaceuticals Ltd
Registered Office: Plot # P-1 & P-2 IT BT Park,Phase II MIDC Hinjawadi , Pune - 411057 , Maharashtra , India.
Phone : +91 20 3507 0033/+91 20 3507 0000   Fax:
Email :  investors@emcure.com  
Website :  www.emcure.com
Initial public offering of 19,375,070 equity shares of face value of 10 each ("Equity Shares") of Emcure Pharmaceuticals Limited (The "Company") for cash at a price of 1,008^ per equity share (including a share premium of 998 per equity share) (the "Offer Price") aggregating to 1952.03^ crores (the "Offer") comprising a fresh issue of 7,946,231 equity shares of face value of 10 each aggregating to 800.00^ crores by the company (the "Fresh Issue") and an offer for sale of 11,428,839 equity shares of face value of 10 each aggregating to 1152.03 crores including 420,000 equity shares of face value of 10 each aggregating to 42.34 crores by Satish Ramanlal Mehta, 1,268,600 equity shares of face value of 10 each aggregating to 127.88 crores by Namita Vikas Thapar, 10,000 equity shares of face value of 10 each aggregating to 1.01 crores by Samit Satish Mehta and 40,000 equity shares of face value of 10 each aggregating to 4.03 crores by Sunil Rajanikant Mehta (the "Promoter Selling Shareholders"), 7,234,085 equity shares of face value of 10 each aggregating to 729.20 crores by BC Investments iv limited (the "Investor Selling Shareholder"), 1,342,586 equity shares of face value of 10 each aggregating to 135.33 crores by the promoter group selling shareholders as set out under annexure a (the "Promoter Group Selling Shareholders"), 300,000 equity shares of face value of 10 each aggregating to 30.24 crores by Arunkumar Purshotamlal Khanna (the "Individual Selling Shareholder"), and 813,568 equity shares of face value of 10 each aggregating to 82.01 crores by other selling shareholders as set out under annexure a (the "Other Selling Shareholders", and collectively with the promoter selling shareholders, promoter group selling shareholders, individual selling shareholder and the investor selling shareholder, the "Selling Shareholders", and each individually, as a "Selling Shareholder" and such offer for sale of equity shares of face value of 10 each by the selling shareholders, the "Offer for sale"). The offer included a reservation of 108,900 equity shares of face value of 10 each, aggregating to 10.00 crores^, for subscription by eligible employees (constituting up to 0.06% of the post-offer paid-up equity share capital)(the "Employee Reservation Portion"). The company, in consultation with the book running lead managers, offered a discount of 8.93% to the offer price (equivalent to 90 per equity share) to eligible employees biddng under the employee reservation portion ("Employee Discount"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constituted 10.25% and 10.19%, respectively, of the post-offer paid-up equity share capital of the company. Tthe face value of the equity share is 10 each and the offer price is 100.80 times the face value of equity shares. ^A discount of 90 per equity share was offered to eligible employees bidding in the employee reservation portion.

Issue Money Payable On
Opens On Closes On Application Allotment
03-Jul-24 05-Jul-24 Rs1008.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :14  Further Multiples of :14

  RsCr Lead Managers to the Issue
Project Cost 758.86
Axis Capital Ltd
Project Financed through Current Offer 1952.03  
Post Issue Equity Share Capital 189.10  
Issue Price Rs1008.00  
 
Projects
 Prepayment or Scheduled Repayment of all or a portion of certain Outstanding Borrowings availed by the Company General Corporate Purposes
Promoted By
 Satish Ramanlal Mehta
 Sunil Rajanikant Mehta
 Namita Vikas Thapar
Listing At
 BSE 
 NSE 
Registrar to the Issue
 Link Intime India Pvt Ltd